1. Home
  2. CMCT vs MBRX Comparison

CMCT vs MBRX Comparison

Compare CMCT & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Media & Community Trust Corporation

CMCT

Creative Media & Community Trust Corporation

HOLD

Current Price

$4.96

Market Cap

12.8M

Sector

Real Estate

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$2.46

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCT
MBRX
Founded
1993
2015
Country
United States
United States
Employees
5
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
13.2M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
CMCT
MBRX
Price
$4.96
$2.46
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$61.00
AVG Volume (30 Days)
34.5K
171.6K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,669,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.25
52 Week High
$14.41
$7.98

Technical Indicators

Market Signals
Indicator
CMCT
MBRX
Relative Strength Index (RSI) 53.41 53.95
Support Level $4.75 $2.24
Resistance Level $5.08 $2.58
Average True Range (ATR) 0.53 0.17
MACD -0.25 0.01
Stochastic Oscillator 20.15 82.29

Price Performance

Historical Comparison
CMCT
MBRX

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is a Maryland corporation and REIT. It mainly acquires, develops, owns, and operates both multifamily properties situated in vibrant communities throughout the United States and Class A and creative office real assets in markets with similar business and employment characteristics to multifamily investments. All of its communities are located in areas that include traditional downtowns and suburban main streets, which have high barriers to entry, high population density, positive population trends, and a propensity for growth. Currently, the company consists of three types of commercial real estate properties, namely office, hotel, and multifamily.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: